Close

Legal

Since the early 1970s, Dr. Peter Breggin has been active as a medical expert in malpractice and product liability suits, as well as criminal cases in which psychiatric or psychoactive drugs have contributed to abnormal behavior. He has also testified in cases involving involuntary treatment, electroshock treatment, and psychosurgery. He has testified more than 70 times in court.

In the 1990s, Dr. Breggin was chosen to be the medical and scientific expert for nearly 200 combined Prozac product liability suits against Eli Lilly and Company. This resulted in his testifying in the infamous Wesbecker case in which the manufacturer, Eli Lilly, fixed the trial. Link. Later Dr. Breggin would become an expert in many other product liability suits involving antidepressants, stimulants, tranquilizers and antipsychotic drugs, nearly all of which were settled. As an expert in these product liability suits, the courts have empowered Dr. Breggin to examine secret company records concerning the development and marketing of their drugs. This unique experience of looking inside otherwise hidden drug company files has provided him a unique source of information and a special understanding of drug company activities that he has used in his legal work and documented in many publications, including Brain-Disabling Treatments in Psychiatry (2008) and Medication Madness (2008).

Among his proudest achievements, in the early 1970s Dr. Breggin was the medical expert in the famous Kaimowitz case that stopped lobotomy and psychosurgery in America’s state mental hospitals. LINK More recently he was the psychiatric expert in a psychosurgery case against the Cleveland Clinic that resulted in a huge verdict for the injured woman and caused the clinic to stop doing any further psychosurgery. LINK Dr. Breggin was also the medical expert in the only electroshock malpractice suit to be won by the plaintiffs. LINK.

Some of Dr. Breggin’s most successful legal work has involved testimony in tardive dyskinesia malpractice suits involving this usually irreversible abnormal movement disorder commonly caused by antipsychotic or neuroleptic drugs. In all but one of the many TD trials in which he has participated in the United States and Canada, the injured patient has won a favorable verdict. The one exception ended in a hung jury. He has also been involved in tardive dyskinesia cases with multi-million dollar settlements without going to trial in both the United States and Canada.

Dr. Breggin continues with both his clinical practice and his medical expert work.

The Hazards of Treating “Attention-Deficit/Hyperactivity Disorder” with Methylphenidate (Ritalin) (1995)

Originally published in The Journal of College Student Psychotherapy, Vol. 10(2) 1995, pp. 55-72 by Peter R. Breggin, M.D. and Ginger Ross Breggin ABSTRACT. The criteria for Attention-Deficit/Hyperactivity Disorder focus on behaviors that adults find frustrating and disruptive. Conflicts between children and adults are redefined as diseases or disorders within the children. Treatment with stimulant […]

Read More